FDA Authorizes First Generic Single-Dose Flu Medication

The U.S. Food and Drug Administration has approved the initial generic form of Xofluza (baloxavir marboxil) tablets. This marks the first single-dose treatment for acute uncomplicated influenza and for prevention in individuals aged five and above, aiming to broaden access to this crucial antiviral drug.